{"id":"W2892880340","doi":"10.1111/ejn.14173","title":"Viewpoint: Developing drugs for levodopa‐induced dyskinesia in <scp>PD</scp>: Lessons learnt, what does the future hold?","year":2018,"lang":"en","type":"article","venue":"European Journal of Neuroscience","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Atuka (Canada); Toronto Western Hospital","funders":"Canadian Institutes of Health Research","keywords":"Tolerability; Dyskinesia; Clinical trial; Medicine; Drug development; Translational research; Investigational Drugs; Preclinical testing; Intensive care medicine; Drug; Pharmacology; Medical physics; Adverse effect; Disease; Parkinson's disease; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009389307,0.0007265505,0.001320253,0.0007474337,0.0009856907,0.003850076,0.001868103,0.007552869,0.009489002],"category_scores_gemma":[0.01165827,0.0002402282,0.001091231,0.0004241711,0.0046898,0.009190272,0.002036052,0.01364765,0.006602817],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001768324,"about_ca_system_score_gemma":0.004947554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001329052,"about_ca_topic_score_gemma":0.002899298,"domain_scores_codex":[0.9979425,0.0006704211,0.0002219205,0.0003622498,0.0006331718,0.0001698091],"domain_scores_gemma":[0.9882858,0.006118885,0.0006883355,0.0005075517,0.003223859,0.001175557],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005138746,0.0001907486,0.0007644456,0.003950739,0.0001525462,0.001150211,0.0004104261,0.0005495574,0.003997793,0.05735757,0.625574,0.305388],"study_design_scores_gemma":[0.0002316817,0.0006013053,0.001017684,0.002437237,0.0001555,0.002058718,0.0007273945,0.0005077884,0.002035868,0.09735845,0.8927657,0.0001026967],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.001308738,0.1877881,0.003956801,0.7742898,0.02460773,0.00003880769,0.0003811251,0.0001943676,0.007434454],"genre_scores_gemma":[0.03063825,0.2769199,0.01056486,0.6047102,0.064325,0.0001405337,0.0004264111,0.0001793507,0.01209555],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.009489002,"threshold_uncertainty_score":0.04965603,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05376196040900744,"score_gpt":0.3376252484893431,"score_spread":0.2838632880803356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}